$2.00
-0.02-0.99%
Last update: Nov 6, 4:52 AM
Adagene Inc (ADAG) Stock Price, Quote, News & History
ADAGNASDAQ
Adagene presents results at ASCO 2024 Gastrointestinal Cancers Symposium. ADG126, combined with Merck's Keytruda, shows limited toxicity, sustained partial...
You can purchase shares of Adagene (NASDAQ:ADAG) through any online brokerage.
Other companies in Adagene’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Adagene has a consensus price target of $8.40.
The stock price for Adagene (NASDAQ: ADAG) is $2.25 last updated November 6, 2026 at 4:52 AM EST.
There are no upcoming dividends for Adagene.
Adagene does not have any upcoming earnings scheduled.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies....
